Navigation Links
COPD Patients In US Are Not Receiving 'Ideal Care'

The researchers from Massachusetts and North Carolina have found that very few of the patients who are hospitalised for treatment of conditions //that have resulted due to chronic obstructive pulmonary disease (COPD) such as emphysema, chronic bronchitis receive proper and ideal care and management.

Explaining that ideal care means getting all the tests, treatments and interventions recommended in the treatment guidelines for this condition and none of those that are not warranted for the condition, they said that the American College of Physicians and American College of Chest Physicians, there are five elements of care that are recommended as "ideal care" for COPD patients.

Dr. Peter K. Lindenauer, from Baystate Medical Center in Springfield, Massachusetts, and his colleagues have explained in the Annals of Internal Medicine that COPD exacerbation is among, one of the ten most common reasons for hospital admission among adults in US and it accounts for over $18 billion in annual healthcare costs. The researchers analysed the data from nearly 70,000 patients hospitalised because of and attack of COPD in US in 2001, so as to determine the percentage of patients who received ideal care in agreement with the guidelines that are given.

They found that 66% of the patients they analysed had received all of the recommended interventions, while 45% of them received at least one non-recommended intervention. They further found that only 33%of subjects had received all of the recommended interventions and none of the non-recommended ones.

They said that a wide inconsistency was seen among the hospitals for the management of COPD patients. They concluded their report by explaining that the quality of care for patients hospitalised for acute exacerbations of COPD could be improved by, increasing the use recommended therapies, decreasing the use of unnecessary treatments that could turn out to be potentially harmful, and on redu cing differences in practice across hospitals.


'"/>




Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patients often assume wrongly that they are allergic to penicillin
7. New FDA Approved Drug NATRECOR For Heart Failure Patients
8. Hemochromatosis Patients Blood is Safe
9. Patients Pressure Would Result In Overprescription
10. Risk Of Decongestants In Hypertensive Patients
11. Interference helps Heart Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/15/2017)... CA (PRWEB) , ... January 15, 2017 , ... ... their choice of best physicians in eight Bay Area counties for 2017. Almost ... the healthcare research company managing the award process. Results were announced the magazine’s ...
(Date:1/14/2017)... ... 2017 , ... Healthy living brand Moody Zook recently came ... With more and more people opting to go organic in their lifestyle, the ... to specific needs. , Moody Zook focused particularly on their newly launched activated ...
(Date:1/13/2017)... California (PRWEB) , ... January 13, 2017 , ... ... carbohydrates that raise blood sugar levels. Counting carbohydrates is as easy as checking ... the only nutrient that affects blood sugar levels. Despite being sugar-free, proteins can ...
(Date:1/13/2017)... ... January 13, 2017 , ... ... taken on the challenge of providing additional organic alternatives for customers who have ... of the brand’s new line of all-natural activated charcoal products, Moody Zook Chief ...
(Date:1/13/2017)... PA (PRWEB) , ... January 13, 2017 , ... "We ... and attractive to wear," said one of two inventors from Virginia Beach, Va. , ... to normally mundane braces. , The accessories allow braces to be customized to ...
Breaking Medicine News(10 mins):
(Date:1/12/2017)... -- BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company developing ... this week,s Orlando Dermatology Aesthetic & Clinical (ODAC) Conference, which ... inflammation. The data will be shared in a ... at ODAC, which is being held Jan. 13-16 in ... ...
(Date:1/12/2017)...   TyrNovo , s NT219 drug candidate ... cancer drug resistance and would be ... NT219 is a novel proprietary ... ( IRS1/2 and STAT3) highly involved in ... .   NT219 has demonstrated ...
(Date:1/12/2017)... -- "Global Lung Cancer Vaccine Market & Pipeline ... trends in the global lung cancer vaccine market. ... available in the market. This report analyzes the ... in clinical pipeline and gives comprehensive clinical insight ... the lung cancer vaccines. Currently there are 9 ...
Breaking Medicine Technology: